On this episode of Oncology Onward, Dr. Debra Patt, executive vice president of policy and strategic initiatives and director of public policy at Texas Oncology joins cohosts Dr Emeline Aviki and Dr Stephen Schleicher for a jam-packed discussion that touches on topics that have never been more timely in the oncology space: the economics behind the current drug shortage, the relationship between pharmacy benefits managers and 340B discounts, and the Inflation Reduction Act.